NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-067-1997-0-FR-14 NOVEL NITRIC OXIDE-RELEASING AMIDINE- AND ENAMINE- DERIVED DIAZENIUMDIOLATES, COMPOSITIONS AND USES THEREOF AND METHOD OF MAKING SAME FR EP 98933062.6 Abandoned
NCI E-067-1997-0-GB-15 NOVEL NITRIC OXIDE-RELEASING AMIDINE- AND ENAMINE- DERIVED DIAZENIUMDIOLATES, COMPOSITIONS AND USES THEREOF AND METHOD OF MAKING SAME GB EP 98933062.6 Abandoned
NCI E-067-1997-0-EP-03 NOVEL NITRIC OXIDE-RELEASING AMIDINE- AND ENAMINE- DERIVED DIAZENIUMDIOLATES, COMPOSITIONS AND USES THEREOF AND METHOD OF MAKING SAME EP National Stage 98933062.6 Abandoned
NCI E-067-1997-0-AU-05 COMPOUNDS FORMED BY THE REACTION OF NITRIC OXIDE WITH AMIDINES AND ENAMINES AS PHARMACEUTICAL AGENTS AU National Stage 82815/98 Abandoned
NCI E-067-1997-0-PCT-02 NOVEL NITRIC OXIDE-RELEASING AMIDINE- AND ENAMINE- DERIVED DIAZENIUM- DIOLATES, COMPOSITIONS AND USES THEREOF AND METHOD OF MAKING SAME PCT PCT PCT/US1998/013723 Expired
NCI E-067-1997-0-CA-06 NITRIC OXIDE-RELEASING AMIDINE-AND ENAMINE-DERIVED DIAZENIUMDIOLATES, COMPOSITIONS AND USES THEREOF CA National Stage 2293501 Abandoned
NCI E-052-1995-1-PCT-03 No_Patent_Title PCT PCT PCT/US98/13542 Abandoned
NCI E-052-1995-1-EP-06 INDUCTION OF ACTIVATED MYELOID DENDRITIC CELL PHENOTYPE EP National Stage 98932972.7 Abandoned
NCI E-052-1995-1-AU-04 Induction of an activated myeloid dendritic cell phenotype AU National Stage 82746/98 Abandoned
NCI E-052-1995-1-CA-05 INDUCTION OF AN ACTIVATED MYELOID DENDRITIC CELL PHENOTYPE CA National Stage 2295229 Abandoned
NCI E-052-1995-1-JP-07 METHOD FOR INDUCING MONOCYTES TO EXHIBIT THE PHENOTYPE OF ACTIVATED MYELOID DENDRITIC CELLS JP National Stage 505868/11 Abandoned
NCI E-216-1997-0-PCT-02 SPECTRAL CLONING-AN INNOVATIVE TECHNICAL AND CONCEPTUAL APPROACH TO THE CLONING AND CHARACTERIZATION OF EVERY CHROMOSOMAL ABBERRATION ... PCT PCT PCT/US1998/013557 Expired
OD E-999-2001-0-US-02 Primate Embryonic Stem Cells US DIV 09/106,390 6200806 Expired PDF
NIBIB E-071-1997-0-CA-03 Method Utilizing Convex Geometry For Laser Capture Microdissection CA National Stage 2294353 Abandoned
NIBIB E-071-1997-0-JP-06 Method Utilizing Convex Geometry For Laser Capture Microdissection JP National Stage 11-505766 Abandoned
NIBIB E-071-1997-0-GB-10 Cylindrical Geometry Adhesive Film System for Laser Capture Microdissection GB EP 98931631.0 Abandoned
NIBIB E-071-1997-0-EP-05 Cylindrical Geometry Adhesive Film System for Laser Capture Microdissection EP National Stage 98931631.0 Abandoned
NIBIB E-071-1997-0-FR-08 Cylindrical Geometry Adhesive Film System for Laser Capture Microdissection FR EP 98931631.0 Abandoned
NIBIB E-071-1997-0-DE-09 Cylindrical Geometry Adhesive Film System for Laser Capture Microdissection DE EP 98931631.0 Abandoned
NIBIB E-071-1997-0-AU-04 Method Utilizing Convex Geometry For Laser Capture Microdissection AU National Stage 81704/98 Abandoned
NIBIB E-071-1997-0-PCT-02 CYLINDRICAL GEOMETERY ADHESIVE FILM SYSTEM FOR LASER CAPTURE MICRODISSECTION PCT PCT PCT/US1998/013318 Expired
NHGRI E-190-1997-0-PCT-02 CLONING OF A GENE MUTATION FOR PARKINSON'S DISEASE PCT PCT PCT/US1998/013071 Expired
NCI E-081-1998-1-US-01 Cytotoxic Metal Chelators and Their Use US 60/090,618 Abandoned
NIAID E-105-1992-0-US-02 ISOLATION, CHARACTERIZATION, AND USE OF THE HUMAN BETA SUBUNIT OF THE HIGH AFFINITY RECEPTOR FOR IMMUNOGLOBULIN E US DIV 09/103,663 6171803 Abandoned PDF
NCI E-216-1994-0-US-04 INHIBITION OF RETROVIRAL LTR PROMOTERS BY CALCIUM RESPONSE MODIFIERS US CON 09/103,519 Abandoned
NCI E-200-1998-0-US-01 Multidrug-Resistant Retroviral Protease Inhibitors, Compostions and Uses Thereof, Bioassay Methods, and Synthesis Methods US 60/090,393 Abandoned
NIDCR E-177-1996-0-PCT-02 SERUM FREE CELL GROWTH MEDIUM PCT PCT PCT/US1998/012958 Expired
NCI E-136-1998-0-US-01 Novel Thiolesters and Uses Thereof US 60/089,842 Abandoned
NIAID E-108-1998-0-US-01 HEPATITIS C VIRUS ENVELOPE PROTEIN MODIFIED FOR EXPRESSION ON THE HOST CELL SURFACE AND USE OF DNA CONSTRUCTS ENCODING THE MODIFIED PROTEIN US 60/089,779 Abandoned
NHGRI E-018-1997-0-CA-05 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR CA National Stage 2295332 Abandoned
NHGRI E-018-1997-0-EP-06 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR AMPLIFIED IN BREAST CANCER EP National Stage 98931358.0 Abandoned
NHGRI E-018-1997-0-AU-04 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR AMPLIFIED IN BREAST CANCER AU National Stage 81506/98 Abandoned
NHGRI E-018-1997-0-PCT-02 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR AMPLIFIED IN BREAST CANCER PCT PCT PCT/US1998/012689 Expired
NHGRI E-018-1997-0-JP-07 AIB1, A NOVEL STEROID RECEPTOR CO-ACTIVATOR AMPLIFIED IN BREAST CANCER JP National Stage Hei 11-504793 Abandoned
NCI E-025-1998-0-US-01 FUSED AZEPINONE CYCLIN DEPENDENT KINASE INHIBITORS US 60/089,619 Abandoned
NCI E-051-1995-1-US-01 Compositions and Methodsfor Modulatin Proteolytic Degradation of Intracellular Targets. US CIP 09/096,889 Abandoned
NCI E-201-1998-0-US-01 SPECIFIC KILLING OF HIV-INFECTED LYMPHOCYTES BY A RECOMBINANT IMMUNOTOXIN DIRECTED AGAINST THE HIV-1 GP 120 ENVELOPE GLYCOPROTEIN US 60/088,860 Abandoned
NINDS E-049-1996-0-US-03 MUTANT FORM OF AN CYTOTOXIC RIBONUCLEOLYTIC PROTEIN WHICH ALLOWS PRODUCTION BY RECOMBINANT METHODS US DIV 09/095,429 6649393 Abandoned PDF
NCI E-008-1998-0-US-01 B2 Microglobulin Fusion Proteins and High Affinity Variants US 60/088,813 Abandoned
NCI E-148-2007-2-US-10 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses US DIV 09/092,077 6194142 Expired PDF
CC E-180-1998-0-US-01 REAL-TIME INTERACTIVE FUNCTIONAL MAGNETIC RESONANCE IMAGING US ORD 09/090,166 Abandoned
NIDDK E-005-1998-0-AU-03 METHODS AND COMPOSITIONS FOR PROTECTING AGAINST CARDIAC ISCHEMIA BY ADMINISTERING ADENOSINE A2A RECEPTOR ANTAGONISTS AU National Stage 63462/98 Abandoned
NIDDK E-005-1998-0-EP-05 METHODS AND COMPOSITIONS FOR PROTECTING AGAINST CARDIAC ISCHEMIA BY ADMINISTERING ADENOSINE A2A RECEPTOR ANTAGONISTS EP National Stage 98907720.1 Abandoned
NIDDK E-005-1998-0-PCT-02 METHODS AND COMPOSITIONS FOR PROTECTING AGAINST CARDIAC ISCHEMIA BY ADMINISTERING ADENOSINE A2A RECEPTOR ANTAGONISTS PCT PCT PCT/US98/004340 Expired
NCI E-160-1997-2-US-01 Polynucleotides Encoding Human FRP and Fragments Thereof US CIP 09/087,031 6479255 Expired PDF
NCI E-160-1997-3-PCT-01 HUMAN FRP AND FRAGEMTS THEREOF INCLUDING METHODS FOR USING THEM PCT PCT COMB PCT/US1998/010974 Expired
NCI E-008-1996-0-US-04 C-C CHEMOKINES THAT INHIBIT RETROVIRUS INFECTION US National Stage 09/077,614 Abandoned
NHGRI E-236-1999-0-US-01 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC US 60/087,220 Abandoned
NIMH E-162-1998-0-US-01 MAMMALIAN GB2 GABAB RECEPTORS US 60/087,274 Abandoned
NICHD E-225-1997-0-PCT-02 USE OF RECOMBINANT HUMAN UTEROGLOBIN IN TREATMENT OF INFLAMMATORY AND FIBROTIC CONDITIONS PCT PCT PCT/US1998/011026 Expired